跳至主要内容
临床试验/NCT05305729
NCT05305729招募中不适用

Metabolic FingerPrinting

Arcensus GmbH5 个研究点 分布在 2 个国家目标入组 10,000 人开始时间: 2021年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10,000
试验地点
5
主要终点
Number of newly identified, disease-specific Metabolic Fingerprints

研究概览

简要总结

The MetaPrint study aims to characterize the metabolic fingerprint of genetic diseases in order to enhance knowledge on the physiological disease status and establish so new tools for diagnosing, monitoring and personalizing treatment of genetic diseases.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
2 Months 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent is obtained from the participant or from the parent/ legal guardian
  • The participant is 2 months or older
  • The participant is diagnosed with a genetic disease
  • The participant is a first degree relative of a subject diagnosed with a genetic disease

排除标准

  • Informed consent is not obtained from the participant or from the parent/ legal guardian
  • The participant is younger than 2 months
  • The participant is not diagnosed with a genetic disease
  • The participant is not a first degree relative of a subject diagnosed with a genetic disease

结局指标

主要结局

Number of newly identified, disease-specific Metabolic Fingerprints

时间窗: 5 years

Plasma-derived metabolite profiles that are specific for a particular genetic disease in comparison to healthy controls and other genetic diseases

次要结局

未报告次要终点

研究者

发起方
Arcensus GmbH
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验